ACRV
Price
$8.08
Change
+$0.02 (+0.25%)
Updated
Sep 6 closing price
61 days until earnings call
DNLI
Price
$25.25
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
54 days until earnings call
Ad is loading...

ACRV vs DNLI

Header iconACRV vs DNLI Comparison
Open Charts ACRV vs DNLIBanner chart's image
Acrivon Therapeutics
Price$8.08
Change+$0.02 (+0.25%)
Volume$63.74K
CapitalizationN/A
Denali Therapeutics
Price$25.25
Change-$0.00 (-0.00%)
Volume$695.24K
CapitalizationN/A
View a ticker or compare two or three
ACRV vs DNLI Comparison Chart
Loading...
ACRV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ACRV vs. DNLI commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRV is a Hold and DNLI is a Buy.

COMPARISON
Comparison
Sep 08, 2024
Stock price -- (ACRV: $8.06 vs. DNLI: $25.26)
Brand notoriety: ACRV and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRV: 129% vs. DNLI: 69%
Market capitalization -- ACRV: $250.26M vs. DNLI: $3.61B
ACRV [@Biotechnology] is valued at $250.26M. DNLI’s [@Biotechnology] market capitalization is $3.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $584.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRV’s FA Score shows that 1 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • ACRV’s FA Score: 1 green, 4 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, ACRV is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRV’s TA Score shows that 4 TA indicator(s) are bullish while DNLI’s TA Score has 6 bullish TA indicator(s).

  • ACRV’s TA Score: 4 bullish, 5 bearish.
  • DNLI’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than ACRV.

Price Growth

ACRV (@Biotechnology) experienced а -19.24% price change this week, while DNLI (@Biotechnology) price change was +3.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.71%. For the same industry, the average monthly price growth was +3.67%, and the average quarterly price growth was -3.87%.

Reported Earning Dates

ACRV is expected to report earnings on Nov 07, 2024.

DNLI is expected to report earnings on Oct 31, 2024.

Industries' Descriptions

@Biotechnology (-2.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.62B) has a higher market cap than ACRV($250M). ACRV YTD gains are higher at: 63.821 vs. DNLI (17.731). ACRV has higher annual earnings (EBITDA): -75.56M vs. DNLI (-486.71M). DNLI has more cash in the bank: 896M vs. ACRV (181M). ACRV has less debt than DNLI: ACRV (4.22M) vs DNLI (48.8M). DNLI has higher revenues than ACRV: DNLI (1.27M) vs ACRV (0).
ACRVDNLIACRV / DNLI
Capitalization250M3.62B7%
EBITDA-75.56M-486.71M16%
Gain YTD63.82117.731360%
P/E RatioN/AN/A-
Revenue01.27M-
Total Cash181M896M20%
Total Debt4.22M48.8M9%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
87
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACRVDNLI
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
90%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 10 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Ad is loading...
ACRV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEVRX22.62-0.02
-0.09%
First Eagle US Value R6
RYPIX56.36-0.23
-0.41%
Rydex Transportation Inv
STITX9.51-0.05
-0.52%
Virtus SGA International Growth I
ASVRX10.41-0.08
-0.76%
American Century Small Cap Value R
HFLGX11.72-0.13
-1.10%
Hennessy Cornerstone Large Growth Inv

ACRV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
-1.71%
ALLR - ACRV
48%
Loosely correlated
-0.96%
DNLI - ACRV
35%
Loosely correlated
+0.42%
LYEL - ACRV
35%
Loosely correlated
-7.25%
DAWN - ACRV
34%
Loosely correlated
+4.39%
NRIX - ACRV
32%
Poorly correlated
-1.01%
More

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+0.42%
BEAM - DNLI
65%
Loosely correlated
+0.46%
NTLA - DNLI
64%
Loosely correlated
-1.55%
JANX - DNLI
56%
Loosely correlated
-1.44%
ALEC - DNLI
55%
Loosely correlated
-1.95%
CRSP - DNLI
52%
Loosely correlated
+0.58%
More